Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape; Cancers; Vol. 12, iss. 10

Bibliografiske detaljer
Parent link:Cancers
Vol. 12, iss. 10.— 2020.— [3014, 15 p.]
Institution som forfatter: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий Научно-исследовательский центр "Онкотераностика"
Andre forfattere: Shramova E. I. Elena Ivanovna, Proshkina G. M. Galina Mikhaylovna, Shipunova V. Viktoriya, Ryabova A. Anastasiya, Kamyshinsky R. Roman, Konevega A. Andrey, Shulga (Schulga) A. A. Aleksey Anatolievich, Konovalova E. V. Elena Valerjevna, Telegin G. Georgy, Deev S. M. Sergey Mikhaylovich
Summary:Title screen
We report here a combined anti-cancer therapy directed toward HER2 and EpCAM, common tumor-associated antigens of breast cancer cells. The combined therapeutic effect is achieved owing to two highly toxic proteins—a low immunogenic variant of Pseudomonas aeruginosa exotoxin A and ribonuclease Barnase from Bacillus amyloliquefaciens. The delivery of toxins to cancer cells was carried out by targeting designed ankyrin repeat proteins (DARPins). We have shown that both target agents efficiently accumulate in the tumor. Simultaneous treatment of breast carcinoma-bearing mice with anti-EpCAM fusion toxin based on LoPE and HER2-specific liposomes loaded with Barnase leads to concurrent elimination of primary tumor and metastases. Monotherapy with anti-HER2- or anti-EpCAM-toxins did not produce a comparable effect on metastases. The proposed approach can be considered as a promising strategy for significant improvement of cancer therapy.
Sprog:engelsk
Udgivet: 2020
Fag:
Online adgang:https://doi.org/10.3390/cancers12103014
Format: Electronisk Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=664919

MARC

LEADER 00000naa0a2200000 4500
001 664919
005 20250124133411.0
035 |a (RuTPU)RU\TPU\network\36104 
035 |a RU\TPU\network\36092 
090 |a 664919 
100 |a 20210528d2020 k||y0rusy50 ba 
101 0 |a eng 
102 |a CH 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape  |f E. I. Shramova, G. M. Proshkina, V. Shipunova и [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 52 tit.] 
330 |a We report here a combined anti-cancer therapy directed toward HER2 and EpCAM, common tumor-associated antigens of breast cancer cells. The combined therapeutic effect is achieved owing to two highly toxic proteins—a low immunogenic variant of Pseudomonas aeruginosa exotoxin A and ribonuclease Barnase from Bacillus amyloliquefaciens. The delivery of toxins to cancer cells was carried out by targeting designed ankyrin repeat proteins (DARPins). We have shown that both target agents efficiently accumulate in the tumor. Simultaneous treatment of breast carcinoma-bearing mice with anti-EpCAM fusion toxin based on LoPE and HER2-specific liposomes loaded with Barnase leads to concurrent elimination of primary tumor and metastases. Monotherapy with anti-HER2- or anti-EpCAM-toxins did not produce a comparable effect on metastases. The proposed approach can be considered as a promising strategy for significant improvement of cancer therapy. 
461 |t Cancers 
463 |t Vol. 12, iss. 10  |v [3014, 15 p.]  |d 2020 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a barnase 
610 1 |a liposomes 
610 1 |a HER2 
610 1 |a EpCAM 
610 1 |a cancer therapy 
610 1 |a липосомы 
610 1 |a противораковая активность 
610 1 |a терапия 
701 1 |a Shramova  |b E. I.  |g Elena Ivanovna 
701 1 |a Proshkina  |b G. M.  |g Galina Mikhaylovna 
701 1 |a Shipunova  |b V.  |g Viktoriya 
701 1 |a Ryabova  |b A.  |g Anastasiya 
701 1 |a Kamyshinsky  |b R.  |g Roman 
701 1 |a Konevega  |b A.  |g Andrey 
701 1 |a Shulga (Schulga)  |b A. A.  |c biologist  |c Researcher, Tomsk Polytechnic University, Candidate of Biological Sciences  |f 1960-  |g Aleksey Anatolievich  |9 22432 
701 1 |a Konovalova  |b E. V.  |c specialist in the field of chemical technology and biotechnology  |c engineer at Tomsk Polytechnic University  |f 1985-  |g Elena Valerjevna  |9 88562 
701 1 |a Telegin  |b G.  |g Georgy 
701 1 |a Deev  |b S. M.  |c biologist  |c Leading Researcher, Tomsk Polytechnic University, Doctor of Biological Sciences  |f 1951-  |g Sergey Mikhaylovich  |3 (RuTPU)RU\TPU\pers\39299 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа химических и биомедицинских технологий  |b Научно-исследовательский центр "Онкотераностика"  |3 (RuTPU)RU\TPU\col\27561 
801 2 |a RU  |b 63413507  |c 20210528  |g RCR 
856 4 |u https://doi.org/10.3390/cancers12103014 
942 |c CF